ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,567, issued on Aug. 12, was assigned to Jazz Pharmaceuticals Research UK Ltd. (Sittingbourne, Great Britain).
"Use of cannabinoids in the treatment of epilepsy" was invented by Geoffrey Guy (Cambridge, Great Britain) and Volker Knappertz (Cambridge, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the use of cannabidiol (CBD) in the treatment of patients with childhood-onset epilepsy who are concurrently taking immunosuppressant drugs. In particular the immunosuppressant drug is a calcineurin inhibitor. More particularly the immunosuppressant drug is tacrolimus. Where the CBD is used in combination with a...